start str = Phenoxyethanol
sql str = Phenoxyethanol
start str = ethanol
sql str = ethanol
Phenoxyethanol and ethanol

Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease.
Recent patents on CNS drug discovery

Microglia signaling as a target of donepezil.
Neuropharmacology

Attention-modulating effects of cognitive enhancers.
Pharmacology, biochemistry, and behavior

Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease.
Life sciences

A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease.
Psychopharmacology

The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.
Pharmacology, biochemistry, and behavior

Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
ChemMedChem

The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
Behavioural brain research

Recent advances in cholinergic drugs for Alzheimer's disease.
Current opinion in drug discovery & development

Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.
British journal of pharmacology

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Nitric oxide: target for therapeutic strategies in Alzheimer's disease.
Current pharmaceutical design

The 'eye test' in recognition of late-onset Alzheimer's disease.
Archives of gerontology and geriatrics

An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function.
Neuropharmacology

Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.
Journal of neural transmission (Vienna, Austria : 1996)

Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
European journal of pharmacology

[Alzheimer's disease: therapeutic perspectives].
Bulletin de l'Académie nationale de médecine

Drugs used to treat Parkinson's disease, present status and future directions.
CNS & neurological disorders drug targets

Evaluation of muscarinic and nicotinic receptor antagonists on attention and working memory.
Pharmacology, biochemistry, and behavior

Pages: 1  2  3  4  5  6  >  >>  >>|

Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.

Subscribe to the FREE Natural News email newsletter. Your privacy is protected.